Relevant conflicts of interest/financial disclosures: This study was sponsored by the Lesch-Nyhan Syndrome Children's Research Foundation and HD053312. Full financial disclosure and author roles can be found in the online version of this article.
Levodopa is not a useful treatment for Lesch-Nyhan disease†
Article first published online: 31 JAN 2011
Copyright © 2011 Movement Disorder Society
Volume 26, Issue 4, pages 746–749, March 2011
How to Cite
Visser, J. E., Schretlen, D. J., Bloem, B. R. and Jinnah, H. A. (2011), Levodopa is not a useful treatment for Lesch-Nyhan disease. Mov. Disord., 26: 746–749. doi: 10.1002/mds.23478
- Issue published online: 19 APR 2011
- Article first published online: 31 JAN 2011
- Manuscript Accepted: 20 SEP 2010
- Manuscript Revised: 19 AUG 2010
- Manuscript Received: 24 MAY 2010
Additional Supporting Information may be found in the online version of this article.
|MDS_23478_sm_suppinfotab1.pdf||30K||Supporting Information Table: CARE-GIVER BEHAVIORAL RATING FOR WEEKLY MONITORING.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.